Paris - Delayed Quote EUR

Eurofins Scientific SE (ERF.PA)

Compare
45.62
+0.18
+(0.40%)
As of 2:24 PM GMT+1. Market Open.

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Dr. Gilles G. Martin Ph.D. Chairman of the Board & CEO 1.35M -- 1963
Ms. Valerie Hanote Executive Director 400.69k -- 1966
Mr. Laurent Lebras Group Administration & CFO -- -- --
Mr. Bernard Wang Head of Investor Relations -- -- --
Ms. Sandra Hoeylaerts Chief Human Resources Officer -- -- --
Mr. David W. Bryant Senior VP of Strategic Business Development North America -- -- --
Mr. Gabriel Julia Senior VP of Clinical Diagnostics Europe -- -- --
Dr. Timothy S. Oostdyk Executive VP of BioPharma, Genomics & Agrosciences Services North America -- -- --
Mr. Joachim Reichelt Senior Vice President of Food & Feed Testing Europe -- -- --
Ms. Yvoine Remy Senior Vice President of Environment Testing Europe -- -- --

Eurofins Scientific SE

23 Val Fleuri
Luxembourg City, 1526
Luxembourg
352 26 18 53 20 https://www.eurofins.com
Sector:?
Healthcare
Full Time Employees:?
62,000

Description

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

Corporate Governance

Eurofins Scientific SE’s ISS Governance QualityScore as of November 1, 2024 is 5. The pillar scores are Audit: 2; Board: 3; Shareholder Rights: 10; Compensation: 6.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

October 22, 2024 at 10:59 AM UTC

Eurofins Scientific SE Earnings Date

Recent Events

July 3, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers